PRESENTATIONNATION

PRESENTATIONNATION

Browse a growing database of presentations shared by companies worldwide.

Browse

Browse All
All Companies
Presentations
Infographics
Reports
Brochures

Company

Blog
About
Contact

Legal

Privacy Policy
Terms of Service

© 2026 Presentation Nation. All rights reserved.
Built in San Diego by Twenty6 Red, Inc.

Atara+JPM+2024_FINAL - Atara Biotherapeutics | Presentation Nation

HomepageAtara BiotherapeuticsAtara+JPM+2024_FINAL

Atara+JPM+2024_FINAL

Atara Biotherapeutics

Browse presentations, reports, and documents from Atara Biotherapeutics.

Tags

2024

Filter options

All (25)●
brochure (1)○
conference (1)○
investor_presentation (1)○
presentation (22)○

Get the best presentations in your inbox

Join professionals who get a weekly curated collection of top business presentations, investor decks, and industry reports — free.

No spam. Unsubscribe anytime.

Loading viewer...

presentation

Format: PDF presentation

Share:

Atara+JPM+2024_FINAL by Atara Biotherapeutics.

Browse all presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Atara Biotherapeutics

Atara Biotherapeutics 2023 JPMorgan Healthcare Conference

conference

21 Pages

Atara Biotherapeutics 2024 Cell Therapy Cancer Autoimmune

investor_presentation

Similar presentations from other companies

Belden-Q1-2024-Earnings-Slides

presentation

Biodexa Pharmaceuticals

bw-offshore-limited---credit-investor-update-16-november-2023_pt.3

presentation

BW Offshore

investor_presentation

22 Pages

Atara Biotherapeutics_August_2020_768_58768

presentation

Atara Biotherapeutics_August_2021_419_73419

presentation

Atara Biotherapeutics_December_2020_6_64006

presentation

Atara Biotherapeutics_February_2020_651_52651

presentation

ArcBest_September_2021_904_74904

presentation

ArcBest

RMP-March-Investor-Presentation-vFINAL_v001_s1u8ol

presentation

Rice Midstream Partners

VYNE_Corporate_Presentation_8_24_vF

presentation

VYNE Therapeutics

OMCL-August-Investor-Presentation

presentation

OMCL